ALB and neoplasm: Other factors previously identified as influencing the PK of reference bevacizumab, such as tumor burden (measured as the longest tumor diameter in the current study) [1, 2], baseline alkaline phosphatase [11, 12], and baseline albumin [1, 11, 12], were not identified as significant covariates in our analysis.